“I would argue that physicians should generally not switch patients from an INSTI regimen only in light of weight gain, mainly because we don’t know what regimen we should switch these patients to, or if it will help,” said Kristine Erlandson, an associate professor in the Division of Infectious Disease at the University of Colorado Anschutz Medical Campus.